[HTML][HTML] Oral squamous cell carcinomas: state of the field and emerging directions
Oral squamous cell carcinoma (OSCC) develops on the mucosal epithelium of the oral
cavity. It accounts for approximately 90% of oral malignancies and impairs appearance …
cavity. It accounts for approximately 90% of oral malignancies and impairs appearance …
[HTML][HTML] PI3K inhibitors in cancer: clinical implications and adverse effects
The phospatidylinositol-3 kinase (PI3K) pathway is a crucial intracellular signaling pathway
which is mutated or amplified in a wide variety of cancers including breast, gastric, ovarian …
which is mutated or amplified in a wide variety of cancers including breast, gastric, ovarian …
Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action …
JAEM Zecha, JE Raber-Durlacher, RG Nair… - Supportive Care in …, 2016 - Springer
Purpose There is a large body of evidence supporting the efficacy of low level laser therapy
(LLLT), more recently termed photobiomodulation (PBM), for the management of oral …
(LLLT), more recently termed photobiomodulation (PBM), for the management of oral …
[HTML][HTML] Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck
A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - frontiersin.org
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …
Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer
FM Elmenier, DS Lasheen, KAM Abouzid - European journal of medicinal …, 2019 - Elsevier
Abstract Phosphatidylinositol-3 kinase (PI3K) pathway is one of the most frequently activated
pathogenic signaling cascades in human malignancies. PI3K is genetically mutated or …
pathogenic signaling cascades in human malignancies. PI3K is genetically mutated or …
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Oral cancers consist of squamous cell carcinoma (SCC) and other malignancies in the
mouth with varying degrees of invasion and differentiation. For many years, different …
mouth with varying degrees of invasion and differentiation. For many years, different …
Quercetin loaded nanoparticles in targeting cancer: recent development
The spread of metastatic cancer cell is the main cause of death worldwide. Cellular and
molecular basis of the action of phytochemicals in the modulation of metastatic cancer …
molecular basis of the action of phytochemicals in the modulation of metastatic cancer …
Could the biological robustness of low level laser therapy (Photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients
ST Sonis, S Hashemi, JB Epstein, RG Nair… - Oral oncology, 2016 - Elsevier
Low level laser therapy (LLLT) has been noted to be effective in mitigating the development
of oral mucositis among patients being treated with chemoradiation for cancers of the head …
of oral mucositis among patients being treated with chemoradiation for cancers of the head …
An update on the implications of cyclin D1 in oral carcinogenesis
P Ramos‐Garcia, JA Gil‐Montoya, C Scully… - Oral …, 2017 - Wiley Online Library
Cyclin D1 promotes cell cycle progression during G1 phase, a key event in G1‐S transition.
The protein is encoded by gene CCND 1, located in chromosomal band 11q13. Cyclin D1 …
The protein is encoded by gene CCND 1, located in chromosomal band 11q13. Cyclin D1 …
[HTML][HTML] Current insights and progress in the clinical management of head and neck cancer
Simple Summary Head and neck cancer (HNC) incidence has been steadily increasing
since the 1990s. While the multimodal treatment approach for localized HNC is well …
since the 1990s. While the multimodal treatment approach for localized HNC is well …